Similar articles

• MGMT promoter methylation and field defect in sporadic colorectal cancer.

  Shen L, Kondo Y, Rosner GL, Xiao L, Hernandez NS, Vilaythong J, Houlihan PS, Krouse RS, Prasad AR, Einspahr JG, Buckmeier J, Alberts DS, Hamilton SR, Issa JP. Shen L, et al. J Natl Cancer Inst. 2005 Sep 21;97(18):1330-8. doi: 10.1093/jnci/dji275. J Natl Cancer Inst. 2005. PMID: 16174854
• MGMT germline polymorphism is associated with somatic MGMT promoter methylation and gene silencing in colorectal cancer.

  Ogino S, Hazra A, Tranah GJ, Kirkner GJ, Kawasaki T, Nosho K, Ohnishi M, Suemoto Y, Meyerhardt JA, Hunter DJ, Fuchs CS. Ogino S, et al. Carcinogenesis. 2007 Sep;28(9):1985-90. doi: 10.1093/carcin/bgm160. Epub 2007 Jul 9. Carcinogenesis. 2007. PMID: 17621591
• N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.

  Melotte V, Lentjes MH, van den Bosch SM, Hellebrekers DM, de Hoon JP, Wouters KA, Daenen KL, Partouns-Hendriks IE, Stessels F, Louwagie J, Smits KM, Weijenberg MP, Sanduleanu S, Khalid-de Bakker CA, Oort FA, Meijer GA, Jonkers DM, Herman JG, de Bruïne AP, van Engeland M. Melotte V, et al. J Natl Cancer Inst. 2009 Jul 1;101(13):916-27. doi: 10.1093/jnci/djp131. Epub 2009 Jun 17. J Natl Cancer Inst. 2009. PMID: 19535783
• MGMT hypermethylation: a prognostic foe, a predictive friend.

  Jacinto FV, Esteller M. Jacinto FV, et al. DNA Repair (Amst). 2007 Aug 1;6(8):1155-60. doi: 10.1016/j.dnarep.2007.03.013. Epub 2007 May 7. DNA Repair (Amst). 2007. PMID: 17482895 Review.
• MGMT: its role in cancer aetiology and cancer therapeutics.

  Gerson SL. Gerson SL. Nat Rev Cancer. 2004 Apr;4(4):296-307. doi: 10.1038/nrc1319. Nat Rev Cancer. 2004. PMID: 15057289 Review. No abstract available.